1. Trang chủ
  2. » Kỹ Thuật - Công Nghệ

Pharmaceutical Substances Syntheses, Patents, Applications - Part 43 ppt

10 535 0
Tài liệu đã được kiểm tra trùng lặp

Đang tải... (xem toàn văn)

THÔNG TIN TÀI LIỆU

Thông tin cơ bản

Tiêu đề Pharmaceutical Substances Syntheses, Patents, Applications - Part 43 ppt
Trường học Unknown University
Chuyên ngành Pharmaceutical Substances Syntheses, Patents, Applications
Thể loại PowerPoint presentation
Năm xuất bản 1999
Thành phố Unknown City
Định dạng
Số trang 10
Dung lượng 262,64 KB

Các công cụ chuyển đổi và chỉnh sửa cho tài liệu này

Nội dung

numerous combination preparations F: Alodont Warner-Lambert- comb.. CCtylyre Oberlin GB: Calgel Warner-Lambert Fluprim Roche Gola Sella Golagamma Avantgarde J: Neocepacol Lepetit Neocor

Trang 1

Cetylpyridinium chloride C 421

k

2

1 Trade Name(s):

1 D: Cetrotide (ASTA Medica GB: Cetrotide (ASTA Medlca)

k

I AWD; 1999)

!

f Cetylpyridinium chloride

i

ATC: BO5CAO1; D08AJ03; D09AA07; R02AA06

Use: dls~nfectant, antisept~c

! RN: 123-03-5 MF: C,,H,,ClN MW: 340.00 EINECS: 204-593-9

i LD,,: 10 mglkg (M, i.v.); 108 rnglkg (M, p.o.),

E 200 mgkg (R, p.o.1

CN 1-hexadecylpyridinium chloride

pyridine cetyl chloride Cetylpyridinium chloride

Reference(s):

Budesinsky-Protiva, 53 1-532

Formulation(s): eff tabl 1.5 mg, 3 mg; lozenge 1.4 mg; sol 5 mg/lO rnl (0.01 %, 0.05 %); tabl 2 mg

Trade Name(s):

D: Dobendan (Cassella-med) Merocame (Seton)-comb Pcnaten (Johnson &

W~ilfing) I: Borocaina (Schiapparelli Ragaden (Ganassini)

Roland)-comb

numerous combination

preparations

F: Alodont (Warner-Lambert)-

comb

Broncorinol (Roche

Nicholas)-comb

CCtylyre (Oberlin)

GB: Calgel (Warner-Lambert)

Fluprim (Roche) Gola (Sella) Golagamma (Avantgarde) J:

Neocepacol (Lepetit) Neocoricidin (Schering-

Neoformitrol (Sandoz) Neogola (Sella) Noalcool (Sella)

numerous combination preparations

Colgen 123 (Kowa)-comb Pabron Troche (Taisho) Suprol (Iwaki) Cepacol (Lakeside)-comb.; wfm

Cobrex (Reid-Rowell)- comb.; wfrn

Chenodeoxycholic acid

(Chenodiol; Acide chenodtoxycholique;

Chenodesoxycholsaure)

ATC: AOSAAOI Use: choleretic, anticholethithogenic dissolution of cholesterol gallstones

RN: 474-25-9 MF: C24H4004 MW: 392.58 EINECS: 207-481-8

LD,: 100 mgkg (M, i.v.); 3 glkg (M, p.0.);

106 mdkg (R, i.v.); 4 glkg (R, p.0.);

> I d k g (dog, PO.)

CN: (3a,5P,7a)-3,7-dihydroxycholan-24-oic acid

Trang 2

422 C Chenodeoxycholic acid

0 0

0/CH3 H~cAo"XH,

+ HO-CH, -+ E Me ,,\+ - 1

Me H

'"OH H O."' H H

"'OH

methyl 3a,7a-diacetoxy- methyl 3 a 7 ~ - d i o c e t o x y

12a-hydroxycholonote (I) 12-oxocholonote (11)

1 H2N-NH2 H20 H O ~ O H , 200 O C

2 HCI

1 hydrozine hydrote

I Chenodeoxycholic ocid

~ i e s e r , L.F.; Rajagopalan, S.: J Am Chem Soc (JACSAT) 72,5530 (1950)

Hauser, E et a].: Helv Chim Acta (HCACAV) 43, 1595 (1960)

Hofmann, A.F.: Acta Chem Scand (ACHSE7) 17, 173 (1963)

Sato, Y.; Ikekawa, N.: J Org Chem (JOCEAH) 24, 1367 (1959)

purification:

DOS 2 302 744 (Union International; appl 20.1.1973; GB-prior 20.1.1972)

DE 2 404 102 (Schering AG; appl 25.1.1974)

DOS 2 613 346 (Diamalt; appl 29.3.1976)

US 4 163 017 (Diamalt; 31.7.1979; D-prior 29.3.1976)

JP-appl 52 153 955 (Tokyo Tanabe; appl 18.6.1976)

isolation from animal bile:

US 3 919 266 (Intellectual Property Dev Corp.; 11.1 1.1975; prior 21.9.1972, 19 - 1973)

US 4 014 908 (Intellectual property Dev ~ o r p ; 29.3.1977; prior 21.9.1972, 19.1 1.1973,7.5.1974, 30.5.1974, 20.2.1976)

US 4 072 695 (Intellectual Property Dev Corp.; 7.2.1978; prior 21.9.1972, 19.1 1.1973, 7.5.1974, 30.5.1974, 20.2.1976, 17.9.1976)

combination with hymecromone:

DOS 2 700 085 (Lipha; appl 4.1.1977; F-prior 13.7.1976)

Trade Nante(s):

D: Chenofalk (Falk) Hekbilin (Strathmann)- GB: Chendol (CP Pharrn.)

F: ChCnodex (Hoechst HoudC) Chenossil (Midy)

Trang 3

Chloral hvdrate C 423

Fluibil (Zambon Italia) Cholasa ('Tokyo Tanabe) USA: Chcnix (Reid-Rowell);

Use: hypnotic, scdative RN: 302-17-0 MF: C,H,CI,O, MW: 165.40 EINECS: 206-1 17-5

LD56 530 mglkg (M, i.v.); 1100 mglkg (M, p.o.1;

479 m a g (R, p.0.)

CN: 2,2,2-trichloro-1 ,l -ethanediol

ethanol trichloro- 1 Chlarol hydrate

acetaldehyde (1)

Reference(s1:

UUmanns Encykl Tech Chem., 4 Aufl., Vol 9, 377

Formulation(s): cps 250 mg, 500 mg

Trade Nume(s):

D: Chloraldurat (Pohl) GB: Welldorm elixir (S & N) USA: Noctec (Squibb); wrm F: numerous combination I: Cloral (Tariff Nazionale) generica

Chloralodol

(Chlorhexadol)

ATC: N05CC02 Use: hypnotic

RN: 3563-58-4 MF: C,HI,C1303 MW: 265.56 EINECS: 222-634-9

CN: 2-methyl-4-(2,2,2-trichloro-1-hydroxyethoxy)-2-pentanol

2-methylpentane- chloral hydrate

2,4-diol

Reference(s):

U S 2 931 838 (Det Danske Med.-& Kern.-Komp.; 5.4.1960; DK-prior 8.12.1956)

Fonnulation(s): tabl 400 mg, 800 mg

Trang 4

424 C Chlorambucil

Trade Narne(s):

GB: Medodorm (Medo); wfm

Use: antineoplastic RN: 305-03-3 MF: C,,H,,C12N02 MW: 304.22 EINECS: 206-162-0

LD,,,: 80 m g k g (M, p.0.);

76 m g k g (R, p.0.)

CN: 4-[bis(2-chloroethyl)amino]benzenebutanoic acid

ocetanilide succinic 4-(4-ocetamidophenyl)-

anhydride 4-oxobutanoic ocid

oxide 4-(4-ominopheny1)-

Reference(s):

US 3 046 301 (Borroughs Wellcome; 24.7.1962; prior 29.10.1959)

1 POCI,

2 H 2 0

1 phosphorus ~ld

Formulation(s): drg 2 mg; tabl 2 mg, 5 mg

oxychlaride

Trade Narne(s):

D: Leukeran (Glaxo GB: Leukeran (Glaxo Linfolysin (Nuovo ISM)

F: Chloraminophtne (Techni- I: Leukeran (Glaxo Wellcome)

Chlorambucil

JOlBAOl; SOlAAOl; S02AAO1; S03AA08

Use: antibiotic RN: 56-75-7 MF: C, ,H12C12N20, MW: 323.13 EINECS: 200-287-4

LD,,,: 110 m g k g (M, i.v.); 1500 mglkg (M, p.0.);

171 mg/kg (R, i.v.); 2500 mg/kg (R, p.0.)

CN: [R-(R*,R*)]-2,2-dichloro-N-[2-hydroxy-l-(hydroxymethyl)-2-(4-nitrophenyl)ethyl]aceta~de

Trang 5

Chloramphenicol C 425

2 HCI

1 hexamethylene- "."-"a OH.[

4'-nitro-

acetophenone

2-bromo-4'-nitro- ocetophenone

2-amino-4'-nitroaceto- phenone hydrochloride (I)

acetic anhydride 2-acetamido-4'-nitro-

acetophenone

D-camphorsulfonic ocid

1 Chloramphenicol I

H C CH,

cinnarnyl

alcohol

2 - b r o m o - l - phenyl-12- proponediol

5-bromo-2.2- dimethyl-4- phenyl-l,3- dioxane (IV)

DL-threo-5-

omino-2.2-

dirnethyl-4-

phenyl-

1.3-dioxone

D(-)-threo-5- amino-2,2- dirnethyl-4- phenyl-1,3- dioxane

D(-)-threo-5-di- chloroacetarnido- 2.2-dimethyl-4- phenyl-1.3-dioxane (V)

Trang 6

426 C Chloramphenicol

p h e n y l ) 1,3-propane-

dial dinitrate

Rqference(s):

Ehrhart-Ruschig IV, 398 ff

a Long, L.M.; Troutman, H.D.: J Am Chem Soc (JACSAT) 71,2469,2473 (1949)

US 2 483 871 (Parke Davis; 1949; appl 1948)

US 2 483 884 (Parke Davis; 1949; appl 1948)

US 2 483 885 (Parke Davis; 1949; appl 1949)

US 2 483 892 (Parke Davis; 1949; appl 1948)

US 2 687 434 (Parke Davis; 1954; appl 1953)

US 2 651 661 (Monsanto; 1953; appl 1950)

US 2 786 870 (Parke Davis; 1957; appl 1954)

Rebstock, M.C et al.: J Am Chem Soc (JACSAT) 71,2458-2468 (1949)

b BE 539 991 (Boehringer Mannh.; appl 1955; D-prior 1954)

DE 1 01 6 718 (Boehringer Mannh.; appl 1953)

BE 558 378 (Boehringer Mannh.; appl 14.6.1957; D-prior 27.6.1956,22.12.1956)

alternative synthesis (from benzaldehyde and nitromethane o r 0-nitroethanolvia 2-n~tro-1-phenyl- l,3- propanediol):

DE 862 302 (Parke D a m ; appl 1949; USA-prior 1948)

DE I 064 937 (Roehringer Mannh.; appl 1957)

DOS 2 708 301 (Egyt; appl 25.2.1977; H-pnor 25.2.1976)

0-3-monophosphate:

DAS 1 668 96 1 (Roussel-Uclaf; appl 20.2.1968; I-prior 20.2.1967, 18.5.1967)

Formulation(s): amp 1 g (as hydrogen succinate sodium salt); cps 250 mg, 500 mg; ear drops 5 g/100 ml,

50 mglg; eye drops 5 mg, 10 mg; ointment 1 % (10 mglg) Trade Name(s):

D: Aquamycetin (Winzer)

Chloramphenicol-PW

(Pharma Wernigerode)

Chloramsaar (Chephasaar)

Oleomycetin (Winzcr)

Paraxin (Boehringer

Mannh.)

Thilocanfol C (Alcon)

numerous combination

preparations

F: CCbtdexacol (Chauvin)-

comb

CCbCnicol (Chauvin)

numerous combination

preparations

GB: Chloromycetin (Goldshield) Kemicetine Succinate (Pharmacia & Upjohn) Minims Chloramphenicol (Chauvin)

SNO Phenicol (Chauvin) I: Chemicetina (Carlo Erba) Chloromycetin (Parke Davis)

Cloram (Formulario Naz.) Minims (Smith & Nephew) Mycetin (Farmigea) Sificetina (SIFI) Vitamfenicolo (Allergan)

numerous salts and combination preparations J: Antacin (Sumitorno) Chloromycetin (Sankyo) Kemicetine (Fujisawa) Myclocin (Takeda) Paraxin (Yamanouchi) Synthomycetine (Otsuka) numerous gcncrics and combination preparations USA: Elase-Chloromycetin (Fujisawa)

Trang 7

Chlorazanil C 427

Use: diuretic RN: 500-42-5 MF: C9HRC1N5 MW: 221.65 EINECS: 207-904-6

LD,,: 300 mglkg (M, p.0.);

16 mglkg (R, i.v.)

CN: N-(4-chloropheny1)- 1,3,5-triazine-2,4-diamine

monohydrochloride

RN: 2019-25-2 MF: C,HRC1N5 HC1 MW: 258.1 1 EINECS: 21 7-962-4

1-(4-chlaropheny1)- formic I C ~ o r a z a n i l

biguonide hydrochloride acid

Reference(s):

DE 1 008 303 (Heumann & Co.; appl 1955)

Formulation(s): tabl 150 mg

Trade Name(s):

D: Orpidan-150 (Heumann);

wfm

Use: anticholinergic RN: 522-18-9 MF: C,,H,,ClN,O MW: 435.01 EINECS: 208-323-0

CN: I-[2-[(2-chlorophenyI)phenylmethoxy]ethyl]-4-[(2-methylphenyl)methyl]piperazine

dihydrochloride

RN: 5576-62-5 MF: C,,H,,ClN,O 2HCl MW: 507.93 EINECS: 226-951-3

LD,,: 1400 mglkg (M, p.0.);

66 mgkg (R, i.v.); 3350 mglkg (R, p.0.)

Reference(s):

BE 549 420 (H Morren; appl 10.7.1956),

2-chlarobenz- 1 -(2-hydroxyethyl)-

Formulation(s): tabl 30 mg (as dihydrochloride)

Chlorbenzoxamine hydlyl chloride 4-(2-methylbenzy1)-

piperazine

Trang 8

4 2 8 C Chlorcyclizine

n a d e Name(s):

D: Libratar (UCB); wfm Gastomax (Brocchieri); Libratar (UCB-Smith)

Chlorcy clizine

(Histachlorazine)

ATC: R06AE04 Use: antihistaminic RN: 82-93-9 MF: ClxH2,CIN2 MW: 300.83 EINECS: 201-446-0

CN: 1-[(4-chlorphenyl)phenylmethyl]-4-methylpiperazine

monohydrochloride

RN: 14362-3 1-3 MF: C,,H2,CIN2 HCI MW: 337.29

dihydrochloride

RN: 129-71-5 MF: ClxH2~C1N2 2HCI MW: 373.76

4-chlorobenz- 1 -methyl- / Chlorcyclizine 1

hydryl chlaride piperazine

Reference(s):

US 2 630 435 (Burroughs Wellcome; 1953; prior 1948)

Formulation(s): tabl 50 mg (as hydrochloride)

Trade Name(s):

F: Di-ParalCne (Abbott); wfm I: Clorciclizina (Tariff USA: Mantadil (Burroughs

Di-Paralene (Abbott); wfm hydrocortisone; wfm

Use: tranquilizer RN: 58-25-3 MF: C,,H,,ClN,O MW: 299.76 EINECS: 200-371-0

LD,,,: 95 m g k g (M, i.v.); 200 m g k g (M, p.0.);

165 mg/kg (R, i.v.); 392 mglkg (R, p.0.)

CN: 7-chloro-N-methyl-5-phenyl-3H-1,4-benzodiazepin-2-amine 4-oxide

2-arnino-5-

chlorobenzo-

phenone

6-chloro-2-chloromethyl 4-phenylquinazoline 3-oxide (I)

Trang 9

Chlorhexidine C 429

g

Chlordiazepoxide

f

:: Referencefs):

US 2 893 992 (Hoffmann-La Roche; 7.7.1959; prior 15.5.1958)

1 ,DE 1096 363 (Hoffmann-La Roche; appl 24.4.1959; USA-prior 15.5.1958)

P Stembach, L.H et al.: J Org Chem (JOCEAH) 26, 11 11 (196 1)

1

? Formulation(s): drg 10 mg; f c tabl 5 mg; tabl 5 mg, 10 mg, 25 mg

D: Limbatril (Roche)-comb

Multum (Rosen Pharma)

Radepur (ASTA Medica

AWD)

F: Librax (Roche)-comb

GB: Librium (Roche)

1: Diapatol (Teofarma)-comb

Librium (Roche)

Limbitryl (Roche)-comb

Psicofar (Terapeutico) USA: Librax (Roche Products; as Reliberan (Geymonat) hydrochloride)

Sedans (Ganassini)-comb Librium (Roche Products; Seren Vita (Synthelabo) as hydrochloride) J: Balance (Yamanouchi) Limbitrol (Roche Products)

Sophiamin (Kyowa Yakuhin)

Trakipearl (Hishiyama)

D09AA12; R02AA05; SO1 AX09; S02AA09; S03AA04

Use: antiseptic RN: 55-56-1 MF: C22H,oC12Nlo MW: 505.46 EINECS: 200-238-7

LD,: 24 mgkg (M, i.v.); 25 15 nig/kg (M, p.0.);

21 mgkg (R, i.v.); 9200 pL/kg (R, p.0.)

CN: N,N'-bis(4-chlorophenyl)-3,12-diimino-2,4,11,13-tetraazatetradecanediimidamide

diacetate

RN: 56-95-1 MF: C22H30C12Nlo 2C2H,02 MW: 625.56 EINECS: 200-302-4

dihydrochloride

RN: 3697-42-5 MF: C22H~oC12N~o~2HCI MW: 578.38 EINECS: 223-026-6

LD,,: >5 g/kg (M, s.c.)

di-~.glW~nate

RN: 18472-51-0 MF: C22H30C12NLo 2C6H1207 MW: 897.77 EINECS: 242-354-0

24.2 mglkg (R, i.v.); 2 @kg (R, p.0.)

Trang 10

430 C Chlorhexidine

hexornethylenebis- 4-chlorooniline

(dicyonodiornide) hydrochloride

I Chlorhexidine I

hexornethylenediornine (4-chlorophenyl)-

dihydrochloride dicyonodiomide

Reference(s):

GB 705 838 (ICI; appl 1951; valid from 1952)

1

$

I Formlclation(s): gel 1 g1100 g; powder 1 g1100 g; sol 0.1 g/100 g, 0.2 g1100 g, 1 g/50 ml (as digluconate)

D: Chlorhexamed (Blend-a- Hibidil (Zeneca; as Hibidil (Zeneca)

C hlorhexidindigluconat Hibiscrub (Zeneca; as Hibitane (Zeneca) (Engelhard)

Corsodyl (SmithKline Beecham OTC Medicines) Frubilurgyl (Boehringer Mannh.)

Hansamed (Beiersdorf) numerous combination preparations

F: Antalyre (Boehringer Ing.;

as g1uconate)-comb

Collunovar (Dexo; as gluconate)

Collupressine (SynthClabo;

as g1uconate)-comb

Collustan (Oberlin; as dig1uconate)-comb

Corsadyl (SmithKline Beecham; as digluconate) CytCal (Sinbio; as g1uconate)-comb

Dacryne (Johnson &

Johnson) Diseptine (Nicholas; as g1uconate)-comb

Eludril (Inava; as

digluconate) Hibitane (Zeneca; as gluconate)

Merfene (Novartis; as

- gluconate) Plurexid (Evans; as gluconate) Prexidine (Pred; as gluconate) SepCal (Sinbio; as digluconate) Thiovalone (Eurorga; as diacetate)-comb

GB: Bactigras (Smith &

Nephew) Chlorhexitulle (Hoechst) Corsodyl (SmithKline Beecham)

numerous preparations I: Clorex (Formulario Naz.) Contact (Vaas; as

Lenixil (Eurospital) Neomercurocromo (SIT) Neoxene (Ecobi) Odontoxina (Ipfi) Oramil (Ganassini) Plak Out (Byk Gulden) Sanoral (Kemiprogress) Savlodil (Zeneca)-comb Savlol (Zeneca)-comb Vaxidina (Vaas) Vidermina (Ganassini) J: Hexad01 (Green Cross) Hibiscrub (ICI) Hibitane Digluconate (Sumitorno) Maskin (Maruishi) Pabron (Taisho Seiyaku) White Go1 (Tamagawa Eizai)

White Rive (Eisai) USA: Betasept (Purdue hydrochloride) Frederick; as gluconate) Corsodyl (SmithKline Hibiclens (Zeneca; as

Effetre (Farma3 Medicalex) Hibistat (Zeneca; as

Ngày đăng: 02/07/2014, 02:20

TỪ KHÓA LIÊN QUAN

TÀI LIỆU CÙNG NGƯỜI DÙNG

TÀI LIỆU LIÊN QUAN

w